Canada - English - Health Canada

sanis health inc - entecavir - tablet - 1mg - entecavir 1mg

Australia - English - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - entecavir -

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - entecavir, quantity: 0.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; crospovidone; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3000 - enteclude is indicated for the treatment of chronic hepatitis b virus infection in adults 16 years or older with evidence of active liver inflammation.,this indication is based on histologic, virologic, biochemical and serological responses in nucleoside-treatment na?ve and lamivudine-resistant adult patients with hbeag-positive or hbeag-negative chronic hbv infection with compensated liver disease

Singapore - English - HSA (Health Sciences Authority)

lotus international pte. ltd. - entecavir monohydrate eqv. entecavir - tablet, film coated - entecavir monohydrate eqv. entecavir 0.5mg

Singapore - English - HSA (Health Sciences Authority)

lotus international pte. ltd. - entecavir monohydrate eqv. entecavir - tablet, film coated - entecavir monohydrate eqv. entecavir 1.00mg

Israel - English - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - entecavir as monohydrate - film coated tablets - entecavir as monohydrate 0.5 mg - entecavir - entecavir s.k. is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with: - compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (alt) levels.- decompensated liver disease.

Israel - English - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - entecavir as monohydrate - film coated tablets - entecavir as monohydrate 1 mg - entecavir - entecavir s.k. is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with:- compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (alt) levels.- decompensated liver disease.

Israel - English - Ministry of Health

inovamed pharma ltd, israel - entecavir as monohydrate - film coated tablets - entecavir as monohydrate 0.5 mg - entecavir - entecavir inovamed is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with: - compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (alt) levels. - decompensated liver disease.

Israel - English - Ministry of Health

inovamed pharma ltd, israel - entecavir as monohydrate - film coated tablets - entecavir as monohydrate 1 mg - entecavir - entecavir inovamed is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with: - compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (alt) levels. - decompensated liver disease.

Israel - English - Ministry of Health

trima israel pharmaceutical products maabarot ltd - entecavir as monohydrate - film coated tablets - entecavir as monohydrate 0.5 mg - entecavir - entecavir - trima is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with: - compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (alt) levels. - decompensated liver disease.